News Image

Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update

Provided By GlobeNewswire

Last update: Jul 30, 2025

Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function

Read more at globenewswire.com

ANIKA THERAPEUTICS INC

NASDAQ:ANIK (10/17/2025, 8:00:00 PM)

After market: 9.17 0 (0%)

9.17

+0.08 (+0.88%)



Find more stocks in the Stock Screener

Follow ChartMill for more